Andrea Marie Pliakas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 5 | 2011 | 958 | 0.240 |
Why?
|
| Nucleus Accumbens | 3 | 2006 | 366 | 0.220 |
Why?
|
| Hypokinesia | 1 | 2001 | 23 | 0.200 |
Why?
|
| Receptors, Opioid, kappa | 3 | 2011 | 138 | 0.180 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2002 | 502 | 0.170 |
Why?
|
| Swimming | 4 | 2011 | 208 | 0.120 |
Why?
|
| Narcotic Antagonists | 3 | 2011 | 585 | 0.090 |
Why?
|
| Conditioning, Operant | 2 | 2011 | 310 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2011 | 625 | 0.070 |
Why?
|
| Diltiazem | 1 | 2006 | 131 | 0.060 |
Why?
|
| Catatonia | 1 | 2008 | 178 | 0.060 |
Why?
|
| Microinjections | 2 | 2006 | 321 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2011 | 8181 | 0.060 |
Why?
|
| Encephalitis | 1 | 2008 | 438 | 0.060 |
Why?
|
| Receptors, AMPA | 2 | 2002 | 336 | 0.050 |
Why?
|
| Electroconvulsive Therapy | 1 | 2008 | 500 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 694 | 0.050 |
Why?
|
| Cytidine | 1 | 2002 | 64 | 0.050 |
Why?
|
| Motor Activity | 2 | 2003 | 2715 | 0.050 |
Why?
|
| Dynorphins | 1 | 2001 | 82 | 0.050 |
Why?
|
| Reaction Time | 2 | 2011 | 2082 | 0.050 |
Why?
|
| Rats | 7 | 2011 | 23742 | 0.040 |
Why?
|
| Antidepressive Agents | 2 | 2003 | 2897 | 0.040 |
Why?
|
| Ventral Tegmental Area | 1 | 2001 | 136 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2006 | 824 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2001 | 852 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2001 | 803 | 0.040 |
Why?
|
| Reward | 2 | 2002 | 971 | 0.040 |
Why?
|
| Methylphenidate | 1 | 2002 | 488 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 1206 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2001 | 2919 | 0.030 |
Why?
|
| Immobility Response, Tonic | 1 | 2011 | 13 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2001 | 3395 | 0.020 |
Why?
|
| Depression | 1 | 2011 | 8124 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 2011 | 123 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 150 | 0.020 |
Why?
|
| Self Administration | 1 | 2011 | 390 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2011 | 297 | 0.020 |
Why?
|
| Naltrexone | 1 | 2011 | 317 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7581 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2008 | 314 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 2008 | 121 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 2008 | 305 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 544 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 916 | 0.010 |
Why?
|
| Animals | 7 | 2011 | 168459 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 242 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6228 | 0.010 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2002 | 29 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 888 | 0.010 |
Why?
|
| Desipramine | 1 | 2002 | 182 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2008 | 1596 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2001 | 370 | 0.010 |
Why?
|
| Conditioning, Classical | 1 | 2002 | 368 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 997 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6310 | 0.010 |
Why?
|
| Male | 6 | 2011 | 360804 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2112 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 1736 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 894 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 39967 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1301 | 0.010 |
Why?
|
| Brain | 1 | 2001 | 27112 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 1177 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2008 | 6225 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18252 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39106 | 0.000 |
Why?
|
| Aging | 1 | 2002 | 8708 | 0.000 |
Why?
|
| Adult | 2 | 2008 | 221177 | 0.000 |
Why?
|
| Child | 1 | 2002 | 80153 | 0.000 |
Why?
|
| Humans | 2 | 2008 | 761504 | 0.000 |
Why?
|
| Female | 1 | 2008 | 392644 | 0.000 |
Why?
|